Rachel is an infectious diseases fellow at Mass General Brigham. She is studying the development of antimicrobial resistance in the setting of increasingly widespread use of doxycycline post-exposure prophylaxis (doxy-PEP).
Rachel is an infectious diseases fellow at Mass General Brigham. She is studying the development of antimicrobial resistance in the setting of increasingly widespread use of doxycycline post-exposure prophylaxis (doxy-PEP).